- About Overview
- Diversity, Equity, and Inclusion
- Honors and Awards
- Facts and Figures
- Support the School
- Contact Us
- Dean’s Office
- Dean’s Office Overview
- Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Org Chart
- Patient Care
Industry-sponsored research more likely to favor drug than placebo
By UCSF School of Pharmacy Editorial Staff / Mon Jun 11, 2007
Published results of drug trials sponsored by the pharmaceutical industry are more likely than trials not sponsored by the industry to favor drug over placebo, according to
- Lisa Bero, PhD and Kirby Lee, PharmD, UCSF School of Pharmacy faculty members;
- Peter Bacchetti, PhD, a UCSF School of Medicine faculty member; and
- Fieke Oostvogel of University of Leiden, Netherlands.
Their conclusions and underlying research appeared in PloS Medicine on June 5, 2007.
UCSF study questions drug trial results: When drug companies sponsor research, their products more likely to perform well
- [Factors Associated with Findings of Published Trials of Drug-Drug Comparisons: Why Some Statins Appear More Efficacious than Others][ defunct as of April 24, 2012]
- Industry-Funded Trials Biased Towards Sponsors' Drugs, Study Says
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.